RESEARCH-USE BIOSIMILAR ANTIBODY
Ipilimumab
Monoclonal antibody · IgG1
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies.
TARGETCTLA4
YMonoclonal antibody
CATALOGSC-BS-472
CATALOG NUMBERSC-BS-472
MOLECULAR WEIGHTApprox. 145.38 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies.
Ipilimumab is a recombinant research-use antibody directed against CTLA4.